Send the following on WhatsApp
Continue to Chat天演藥業宣佈其抗CTLA-4抗體ADG126Ib/II期臨床劑量遞增中期數據 https://geneonline.news/%e5%a4%a9%e6%bc%94%e8%97%a5%e6%a5%ad%e5%ae%a3%e4%bd%88%e5%85%b6%e6%8a%97ctla-4%e6%8a%97%e9%ab%94adg126ib-ii%e6%9c%9f%e8%87%a8%e5%ba%8a%e5%8a%91%e9%87%8f%e9%81%9e%e5%a2%9e%e4%b8%ad%e6%9c%9f%e6%95%b8/?variant=zh-cn